Apollo Hospitals Q3 Results: Profit up 35%, revenue beat estimates; dividend declared

Apollo Hospitals Enterprise Ltd reported a strong set of numbers for the December quarter, with performance coming in ahead of Street estimates across key parameters.

The hospital chain posted a consolidated net profit of ₹502.3 crore for Q3FY26, up 35% year-on-year from ₹372.3 crore. This was higher than the CNBC-TV18 poll estimate of ₹426.6 crore.

Revenue from operations rose 17.2% year-on-year to ₹6,477 crore, compared with ₹5,527 crore in the same period last year, and also exceeded the poll estimate of ₹6,231.7 crore.

EBITDA for the quarter stood at ₹965 crore, registering a 26.7% growth over ₹762 crore last year, and beating estimates of ₹877.8 crore. Operating margins expanded to 14.9% from 13.8% a year ago.

Commenting on the performance, Chairman Prathap C Reddy said the quarter reflected the “fundamental strength and clinical depth” of Apollo’s integrated care model, supported by disciplined execution in patient safety, quality and experience. He highlighted progress across high-complexity specialties, including robotics-led joint replacements, expansion of advanced stroke care labs in Chennai, and the launch of a Centre of Excellence for Parkinson’s disease and Deep Brain Stimulation care.

Reddy also pointed to Apollo’s scale in transplants, noting that the group now performs an average of five solid organ transplants a day, with cumulative milestones of over 21,000 kidney transplants and more than 5,000 liver transplants.

Also Read: Eicher Motors Q3 Results: Revenue, margin beat estimates; profit rises 21% YoY

On capacity expansion, Apollo continued its growth momentum with the Phase-1 launch of a 250-bed quaternary care facility in Pune, while also seeing increased traction from its International Patient Services vertical.

The Board of Directors declared an interim dividend of ₹10 per share for FY26. The record date has been fixed as February 16, 2026, with the dividend to be paid on or before February 27, 2026.

Ahead of the earnings announcement, shares of Apollo Hospitals Enterprise Ltd closed marginally higher at ₹7,216 on the NSE.